Wai Yuen Tong Medicine Holdings (HKSE:00897) LT-Debt-to-Total-Asset: 0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00897 Wai Yuen Tong Medicine Holdings Ltd HKSE:00897
38 GF Score
Price HK$0.29
GF Value HK$0.29
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Wai Yuen Tong Medicine Holdings LT-Debt-to-Total-Asset?

Wai Yuen Tong Medicine Holdings HKSE:00897 38 LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus rates HKSE:00897 with a GF Score™ of 38/100 and a GF Value™ of HK$0.29 (Fairly Valued). The stock has 2 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Wai Yuen Tong Medicine Holdings's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.00.

Wai Yuen Tong Medicine Holdings's long-term debt to total assets ratio declined from Mar. 2025 (0.09) to Mar. 2026 (0.00). It may suggest that Wai Yuen Tong Medicine Holdings is progressively becoming less dependent on debt to grow their business.

Wai Yuen Tong Medicine Holdings  (HKSE:00897) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Wai Yuen Tong Medicine Holdings LT-Debt-to-Total-Asset Related Terms

Wai Yuen Tong Medicine Holdings LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Wai Yuen Tong Medicine Holdings's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wai Yuen Tong Medicine Holdings LT-Debt-to-Total-Asset Chart

Wai Yuen Tong Medicine Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.15 0.13 0.09 0.00

Wai Yuen Tong Medicine Holdings Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.09 0.09 0.00 0.00
HKSE:00897
38GF Score
Wai Yuen Tong Medicine Holdings Ltd HKSE:00897
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wai Yuen Tong Medicine Holdings LT-Debt-to-Total-Asset Calculation

Wai Yuen Tong Medicine Holdings's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (A: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2026 )/Total Assets (A: Mar. 2026 )
=0/1626.556
=0.00

Wai Yuen Tong Medicine Holdings's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=0/1626.556
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.00 mean?
Wai Yuen Tong Medicine Holdings (HKSE:00897) has a LT-Debt-to-Total-Asset of 0.00 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Wai Yuen Tong Medicine Holdings and its competitors.
Is Wai Yuen Tong Medicine Holdings' LT-Debt-to-Total-Asset too high?
Wai Yuen Tong Medicine Holdings' current LT-Debt-to-Total-Asset is 0.00. Overall, Wai Yuen Tong Medicine Holdings has a GF Score™ of 38/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wai Yuen Tong Medicine Holdings' LT-Debt-to-Total-Asset compare to ZTS?
Wai Yuen Tong Medicine Holdings' LT-Debt-to-Total-Asset of 0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Wai Yuen Tong Medicine Holdings and its competitors. Wai Yuen Tong Medicine Holdings's current LT-Debt-to-Total-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Yuen Tong Medicine Holdings stock overvalued right now?
Based on GuruFocus' analysis, Wai Yuen Tong Medicine Holdings (HKSE:00897) is currently considered Fairly Valued. The stock's GF Value™ is HK$0.29, compared to a current price of HK$0.29 — trading right at its estimated fair value. The current LT-Debt-to-Total-Asset is 0.00. Wai Yuen Tong Medicine Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Wai Yuen Tong Medicine Holdings (HKSE:00897), the current LT-Debt-to-Total-Asset is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wai Yuen Tong Medicine Holdings (HKSE:00897) Overvalued in 2026?

Based on GuruFocus' analysis, Wai Yuen Tong Medicine Holdings stock appears to be undervalued. The current stock price of HK$0.29 is trading 0% below its estimated GF Value™ of HK$0.29. GuruFocus considers Wai Yuen Tong Medicine Holdings to be Fairly Valued.

Key valuation signals for HKSE:00897:

  • LT-Debt-to-Total-Asset: 0.00
  • GF Value™: HK$0.29 vs. price of HK$0.29 (0% below fair value)
  • GF Score™: 38/100 with 2 warning signs

No single metric tells the full story. See the HKSE:00897 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wai Yuen Tong Medicine Holdings Business Description

Address 39 Wang Kwong Road, Suite 3101, 31st Floor, Skyline Tower, Kowloon Bay, Kowloon, Hong Kong, HKG
Wai Yuen Tong Medicine Holdings Ltd is an investment holding company. The company's operating segment includes production and sale of Chinese pharmaceutical and health food products; production and sale of Western pharmaceutical and health food products and property investment and management and sale of properties. It generates maximum revenue from the production and sale of Chinese pharmaceutical and health food products which include manufacturing, processing, and sale of traditional Chinese medicine which includes Chinese medicinal products sold under the brand name Wai Yuen Tong. Geographically, it derives a majority of revenue from Mainland China.
38GF Score

Get the complete analysis for HKSE:00897

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.29
Price
HK$0.29
GF Value